AYUF Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
MFDS item code 201403491 · Approved 2014.07.29
This product's status changed to Expired on 2024.07.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers and gastritis); prevention of Mendelson syndrome
This medication is used for gastric diseases such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective in preventing ulcers that occur after surgery and treating ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs). It helps prevent Mendelson's syndrome when administered before anesthesia. This medication protects the gastric mucosa and regulates gastric acid secretion, alleviating symptoms and promoting recovery from the disease. As a result, it is used for treating and preventing various gastric-related diseases.
○ Adults Usually, regardless of meals, administer 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose if necessary. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.
This medication should not be used by patients undergoing dialysis or anyone who has previously shown allergic reactions to this drug or its components. Those with a history of the rare condition acute porphyria should also avoid this medication as symptoms may worsen. It is safest not to administer this drug to patients with poor kidney function, those who have undergone gastrointestinal surgery, pregnant women or women with a possibility of pregnancy, and premature infants or neonates. Patients on a potassium-restricted diet should also exercise caution. Special care should be taken when using this medication in patients with impaired liver function, those with drug allergies, the elderly, and those with a history of renal issues. For patients taking NSAIDs, particularly the elderly or those with a history of peptic ulcers, regular health checks are necessary. Since this medication may mask symptoms of gastric cancer, gastric ulcer patients or middle-aged patients with newly developed or changed dyspeptic symptoms should first confirm that there is no malignancy before using it. Patients with gastric or duodenal ulcers infected with Helicobacter pylori should also receive eradication therapy. Critical care patients or those with hypophosphatemia and patients with swallowing difficulties should be closely monitored for potential side effects after using this medication. This medication can rarely cause severe allergic reactions, including anaphylactic shock; if symptoms occur, discontinue use immediately and inform medical personnel. Allergic symptoms such as skin rashes, hives, angioedema, fever, bronchospasm, and hypotension may also occur, and use should be discontinued if these symptoms develop. A variety of side effects have been reported, including decreased blood cell counts, liver function abnormalities, arrhythmias, gastrointestinal symptoms, and neuropsychiatric symptoms; any unusual symptoms should prompt immediate consultation with medical personnel. Long-term use should be avoided, and the treatment progress should be carefully monitored, using the minimum effective dose. The elderly or those with chronic lung diseases, diabetes, or weakened immunity may be at increased risk for pneumonia while taking this medication. If dizziness or drowsiness occurs, it is advisable to avoid driving or operating hazardous machinery. This drug can interact with other medications; if taking other medications, be sure to inform medical personnel, and it may be necessary to space out the dosing times for certain medications. It is safest for pregnant or breastfeeding women not to use this medication, and safety and efficacy have not been sufficiently established in children, so its use is not recommended. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, so seek medical attention immediately. Long-term use of this medication may impact eye health, possibly necessitating regular eye exams.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent air exposure, preferably at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's efficacy for a long time.
Green round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride · Tripotassium Bismuth Dicitrate +1 more
Prescription medication · Combination
Hankook Hyutex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.